Press Releases

HHS Announces Key Milestones in National Plan to Address Alzheimer’s Disease by 2025

June 18, 2013

HHS Announces Key Milestones in National Plan to Address Alzheimer’s Disease by 2025

Update addresses impact of Alzheimer’s-related costs, calls for increased awareness

WomenAgainstAlzheimer’s Embraces Senator Collins’ Call to Double Alzheimer’s Research Funding

May 21, 2013

WomenAgainstAlzheimer’s Embraces Senator Collins’ Call to Double Alzheimer’s Research Funding

Prominent Women Activists and Members of Congress Gather for First WomenAgainstAlzheimer’s Summit

UK to Use Presidency of the G8 to Develop New International Approach to Address Dementia

May 16, 2013

The plan will unite world governments, NGOs, and industry in the fight to stop dementia

WASHINGTON, D.C. – The United Kingdom today announced its plan to use its Presidency of the G8 – the international body comprised of the world’s eight wealthiest Western countries – to develop a new international approach to address Alzheimer’s and dementia by advancing dementia research.

Global CEOi Commits Industry to Innovation and Leadership in the Global Fight Against Alzheimer’s and Dementia

May 1, 2013

CEOi Spotlights Alzheimer’s at 2013 Milken Global Conference, Calls for New Global Framework to Stop Alzheimer’s Disease by 2025

Geoffrey Beene Foundation Alzheimer's Initiative Announces $100,000 Innovation Challenge

April 30, 2013

GEOFFREY BEENE FOUNDATION ALZHEIMER’S INITIATIVE ANNOUNCES $100,000 INNOVATION CHALLENGE

First Open-Source Challenge to Target Male/Female Differences in Early Cognitive Decline

Why 2020?

USAgainstAlzheimer’s has retained its goal of stopping Alzheimer’s by 2020 rather than endorsing the goal of the National Plan to Address Alzheimer’s Disease that calls for preventing and effectively treating the disease by 2025. While we support the national plan and its goals, we believe, as most every family touched by Alzheimer’s disease believes, that preventing and effectively treating Alzheimer's by 2025 is simply too long a wait for concrete progress. There are promising avenues of drug discovery and development that will, if successful, deliver a means of slowing or deferring Alzheimer's symptoms by 2020. By voicing the urgency felt by so many families, we will pressure researchers and industry to do all in their power to make that happen.